Abstract
Virtually all mammalian cells express two seemingly redundant cyclin–D-dependent kinases (Cdk4 and Cdk6) and three partner cyclins (D1, D2 and D3) essential for the G1–S transition, with predominant expression of Cdk4 and D1 in mesenchymal cells and Cdk6 and D3 in hematopoietic cells. We recently found two novel functions for Cdk6 executed in fibroblasts although unlike Cdk4 it is dispensable for their proliferation. In the rat fibroblast NRK-49F cells, oncogenic stimulation recruits Cdk6 to participate in a step of the cell cycle start that seems to be critical for anchorage-independent S-phase onset. Among the kinase-D-type cyclin combinations, the Cdk6–cyclin-D3 complex has a unique ability to evade inhibition by cyclin-dependent kinase inhibitors and thereby control the cell's proliferative competence under growth-suppressive conditions. We describe here that 2–5-fold overexpression of both Cdk6 and D3 enhances by 5×103–106-fold the susceptibility of the BALB/c3T3 and C3H10T1/2 mouse fibroblast lines to ultraviolet irradiation- as well as 3-methylcholanthrene-induced transformation. This result suggests that deregulated expression of Cdk6 and cyclinD3 may predispose cells to malignant transformation, supporting the recent finding that cyclin D3 activated by chromosomal rearrangement is the causative gene of non-Hodgkin B lymphoma, in which Cdk6 is the major partner kinase.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bartkova J, Lukas J, Strauss M and Bartek J . (1998). Oncogene, 17, 1027–1037.
Cenciarelli C, Santa FD, Puri PL, Mattei E, Ricci L, Bucci F, Felsani A and Caruso M . (1999). Mol. Cell. Biol., 19, 5203–5217.
Chilosi M, Doglioni C, Yan Z, Lestani M, Menestrina E, Sorio C, Beneditti A, Vinante E, Pizzolo G and Inghirami G . (1998). Am. J. Pathol., 152, 209–217.
Corcoran MM, Mould SJ, Orchard JA, Ibbotson RE, Chapman RM, Boright AP, Platt C, Tsui LC, Scherer SW and Oscier DG . (1999). Oncogene, 18, 6271–6277.
Costello JF, Plass C, Arap W, Chapman VM, Held WA, Berger MS, Su Huang HJ and Cavenee WK . (1997). Cancer Res., 57, 1250–1254.
Dulic V, Lees E and Reed SI . (1992). Science, 257, 1958–1961.
Easton J, Wei T, Lahti JM and Kidd VJ . (1998). Cancer Res., 58, 2624–2632.
Ebert MPA, Hernberg S, Fei G, Sokolowski A, Schulz HU, Lippert H and Malfertheiner P . (2001). J. Cancer Res. Clin. Oncol., 127, 449–454.
Fang F, Orend G, Watanabe N, Hunter T and Ruoslahti E . (1996). Science, 271, 499–502.
Hall M and Peters G . (1996). Adv. Cancer Res., 68, 67–108.
Herzinger T and Reed SI . (1998). J. Biol. Chem., 273, 14958–14961.
Hunter T and Pines J . (1994). Cell, 79, 573–582.
Jiang W, Zhang YJ, Kahn SM, Hollstein MC, Santella RM, Lu SH, Harris CC, Montesano R, Weinstein IB . (1993). Proc. Natl. Acad. Sci. USA, 90, 9026–9030.
Jinno S, Hung SC and Okayama H . (1999a). Oncogene, 18, 565–571.
Jinno S, Hung SC, Yamamoto H, Lin J, Nagata A and Okayama H . (1999b). Proc. Natl. Acad. Sci. USA, 96, 13197–13202.
Jinno S, Yageta M, Nagata A and Okayama H . (2002). Oncogene, 21, 1777–1784.
Kakunaga T . (1985). IARC Scientific Publication NO. 67: Transformation Assay of Established Cell Lines, Mechanisms and Application. Kakunaga T and Yamasaki H (eds). Oxford University Press: New York, pp 55–73.
Kakunaga T and Crow JD . (1980). Science, 209, 505–507.
Kawada M, Yamagoe S, Murakami Y, Suzuki K, Mizuno S and Uehara Y . (1997). Oncogene, 15, 629–637.
Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza BR and Robert JM . (1992). Science, 257, 1689–1694.
Lebwohl DE, Muise-Helmericks R, Sepp-Lorenzino L, Serve S, Timaul M, Bol R, Borgen P and Rosen N . (1994). Oncogene, 9, 1925–1929.
Lien HC, Lin CW, Huang PH, Chang ML and Hsu SM . (2000). Lab. Invest., 80, 893–900.
Lin J, Jinno S and Okayama H . (2001). Oncogene, 20, 2000–2009.
Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM and Arnold A . (1991). Nature, 350, 512–515.
Okayama H, Nagata A, Jinno S, Murakami H, Tanaka K and Nakashima N . (1996). Adv. Cancer Res., 69, 17–62.
Park DS, Morris EJ, Padmanabhan J, Shelanski ML, Geller HM and Greene LA . (1998). J. Cell Biol., 143, 457–467.
Pines J . (1995). Semin. Cancer Biol., 6, 63–72.
Reznikoff CA, Brankow DW and Heidelberg C . (1973). Cancer Res., 33, 3231–3238.
Robles AI and Conti CJ . (1995). Carcinogenesis, 16, 781–786.
Rogatsky I, Trowbridge JM and Garabedian MJ . (1997). Mol. Cell. Biol., 17, 3181–3193.
Schauer IE, Siriwardana S, Langan TA and Sclafani RA . (1994). Proc. Natl. Acad. Sci. USA, 91, 7827–7831.
Shaughnessy Jr J, Gabrea A, Qi Y, Brents L, Zhan FH, Tian E, Sawyer J, Barlogie B, Bergsagel PL and Kuehl M . (2001). Blood, 98, 217–223.
Sherr CJ . (1996). Science, 274, 1672–1677.
Sonoki T, Harder L, Horsman DE, Karran L, Taniguchi I, Willis TG, Gesk S, Steinemann D, Zucca E, Schlegelberg B, Sole F, Mungall AJ, Gascoyne RD, Siebert R and Dyer MJS . (2001). Blood, 98, 2837–2844.
Timmermann S, Hinds PW and Munger K . (1997). Cell Growth Differ., 8, 361–370.
Van den Heuvel and Harlow E . (1993). Science, 262, 2050–2054.
Wang J and Walsh K . (1996). Cell Growth Differ., 7, 1471–1478.
Weinberg RA . (1995). Cell, 81, 323–330.
Zhu XY, Ohtsubo M, Bohmer RM, Roberts JM and Assoian RK . (1996). J. Cell Biol., 133, 391–403.
Acknowledgements
This work was supported by grants from the Ministry of Education, Science and Culture, Japan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, Q., Lin, J., Jinno, S. et al. Overexpression of Cdk6–cyclin D3 highly sensitizes cells to physical and chemical transformation. Oncogene 22, 992–1001 (2003). https://doi.org/10.1038/sj.onc.1206193
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206193
Keywords
This article is cited by
-
Glabridin arrests cell cycle and inhibits proliferation of hepatocellular carcinoma by suppressing braf/MEK signaling pathway
Tumor Biology (2016)
-
Overexpression of Cdk6 and Ccnd1 in chondrocytes inhibited chondrocyte maturation and caused p53-dependent apoptosis without enhancing proliferation
Oncogene (2014)
-
Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma
Leukemia (2008)
-
G1/S transcriptional networks modulated by the HOX11/TLX1 oncogene of T-cell acute lymphoblastic leukemia
Oncogene (2005)
-
Gene expression patterns in acute myeloid leukemia correlate with centrosome aberrations and numerical chromosome changes
Oncogene (2004)